Get the Stockscreener App
0.00
100.00%
-0.833
Invo Bioscience Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
See More
Previous Close:
$0.833
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.25M
Revenue:
$1.92M
Net Income/Loss:
$-8.81M
P/E Ratio:
0.00
EPS:
-15.86
Net Cash Flow:
$-5.41M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.50
Invo Bioscience Inc Stock (INVO) Company Profile
Name
Invo Bioscience Inc
Sector
Industry
Phone
(978) 878-9505
Address
5582 BROADCAST COURT, SARASOTA
Invo Bioscience Inc Stock (INVO) Latest News
INVO Bioscience, Inc. announced that it has received $0.275 million in funding - Marketscreener.com
INVO Bioscience Closes Wisconsin Fertility Institute Acquisition - Marketscreener.com
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel Invocell System for Use in the Treatment of Infertility - Marketscreener.com
INVO Bioscience, Inc. Announces Appointment of Pressly Ahammed as Director of International Business Development - Marketscreener.com
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific - Marketscreener.com
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 - Marketscreener.com
INVO Bioscience, Inc. Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 - Marketscreener.com
INVO Bioscience Announces the Appointment of Steve Shum as Chief Executive Officer - Marketscreener.com
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
INVO Bioscience, Inc. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC - Marketscreener.com
INVO Bioscience changes name, trading symbol after merger - Business Observer
INVO Bioscience confirms name change, new trading symbol following NAYA merger - TipRanks
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences - The Manila Times
There is no way INVO Bioscience Inc (INVO) can keep these numbers up - SETE News
B Riley Financial (NASDAQ:RILY) Stock Surges After $386M Deal with Oaktree - DRP Journal
INVO Bioscience (NASDAQ: INVO) Stock Sees Bullish Momentum on Merger News - DRP Journal
What Happened With Invo BioScience Stock Today? - Benzinga
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com UK
Sarasota fertility company completes merger with bioscience firm - Business Observer
INVO Bioscience merges with NAYA, eyes oncology market - Investing.com
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) - ForexTV.com
Onto Innovation Inc. (NYSE:ONTO) Shares Acquired by Handelsbanken Fonder AB - Defense World
Hoxton Planning & Management LLC Has $276,000 Stake in Target Co. (NYSE:TGT) - Defense World
INVO Bioscience secures $265,000 through Merchant Cash Advance - Investing.com India
INVO Bioscience secures $265,000 through Merchant Cash Advance By Investing.com - Investing.com UK
Research Analysts’ Weekly Ratings Updates for Innoviz Technologies (INVZ) - Defense World
Financial Health Report: Innoviva Inc (INVA)’s Ratios Tell a Tale - The Dwinnex
Interval Partners LP Has $2.52 Million Stock Holdings in Innoviz Technologies Ltd. (NASDAQ:INVZ) - Defense World
Seven Eight Capital LP Sells 17,969 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
Adversity is less terrifying than hope: Innoviz Technologies Ltd (INVZ) - SETE News
Analytical Lens: Exploring Iovance Biotherapeutics Inc (IOVA)’s Financial Story Through Ratios - The Dwinnex
Take off with Invivyd Inc (IVVD): Get ready for trading - SETE News
Inovio Pharmaceuticals Inc Inc. (INO) Price Performance: How to Use Technical Analysis to Make Trading Decisions - The InvestChronicle
Ratio Revelations: Inovio Pharmaceuticals Inc (INO)’s Financial Metrics in the Spotlight - The Dwinnex
Innoviva, Inc.'s (NASDAQ:INVA) Stock Is Going Strong: Have Financials A Role To Play? - Simply Wall St
(INO) Technical Pivots with Risk Controls - Stock Traders Daily
American Century Companies Inc. Purchases 361,797 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - StockTitan
Innoviz Technologies (NASDAQ:INVZ) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Innodata Target of Unusually Large Options Trading (NASDAQ:INOD) - Defense World
Incyte Insiders Sold US$4.8m Of Shares Suggesting Hesitancy - Simply Wall St
Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World
Pacer Advisors Inc. Buys 2,676,851 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
INVO Bioscience faces Nasdaq delisting over share price - Investing.com India
INVO Bioscience faces Nasdaq delisting over share price By Investing.com - Investing.com Australia
MNC Capital Partners mantaining its $43 a share offer for Vista Outdoor - Arkansas Online
Inspire Investing LLC Sells 7,991 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
INVO Bioscience Risks Nasdaq Delisting Amid Stock Price Woes - TipRanks
Invo Bioscience Inc Stock (INVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):